When you subscribe we ask for your e-mail address.
Perspectives will take you behind the scenes at Novo Nordisk and showcase the views of our management, partners and the people we serve around the world.
When you subscribe, you’ll receive an email when new articles are published – on average once or twice per month.
Novo Nordisk Chief science officer Mads Krogsgaard Thomsen reflects on the past, present and future of insulin in a tablet.
President and chief executive officer of Novo Nordisk, Lars Fruergaard Jørgensen on why the definition of obesity is just the beginning of a broader, more significant discussion.
Change of the obesity conversation
CEO, Lars Fruergaard Jørgensen, reflects on the challenge of providing access to care among vulnerable populations displaced by conflict